Drug Interaction Report

Metipranolol and Acarbose: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Acarbose

Prandase® Precose Precose®
+

Metipranolol

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 58 documented Metipranolol interactions, 52 are rated moderate — including this one.
At a glance Effects may be stronger Effects may be weaker Some uncertainty
The Bottom Line
Using acarbose with the beta-blocker metipranolol can shift your blood sugar and may hide the racing-heart warning sign of a low. Keep both as prescribed, monitor your glucose a bit more closely, and let your care team fine-tune your doses.

Acarbose helps lower your blood sugar, and metipranolol is a beta-blocker (often used as eye drops for glaucoma, though some can reach the bloodstream). When these are used together, two things can happen. First, your blood sugar may swing a little higher or lower than expected. Second, and more important, a beta-blocker can hide some of the usual warning signs of low blood sugar, like a racing heartbeat. You may still feel sweaty, but the pounding-heart cue can be muted.

The good news is this is very manageable. Your care team can check your blood sugar more often and fine-tune your doses. Please don't change anything on your own, just let your pharmacist or doctor know you take both.

Effect: Beta-blockade may alter glycemic control (hypo- or hyperglycemia) and can blunt adrenergic warning signs of hypoglycemia, notably tachycardia, while diaphoresis is typically preserved. Neither acarbose nor metipranolol is a prodrug; this is a pharmacodynamic interaction, not a metabolic activation issue.

  • Mechanism: Altered glucose metabolism plus beta-adrenergic blockade; nonselective agents may potentiate hypoglycemia and impair glucose recovery.
  • Onset: delayed. Evidence: probable. Severity: moderate.
  • Management: Increase frequency of glucose monitoring; individualize antidiabetic dosing. On beta-blocker withdrawal, monitor for loss of glycemic control.
Onset
delayed
Evidence
probable
Severity
Moderate

What happens

Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia

Interaction Deep Dive

When antidiabetic medications are taken together with beta-blockers, the result may be either hypoglycemia or hyperglycemia, and the beta-blockers may also mask the warning signs of low blood sugar 12. Among those signs, tachycardia may be altered, whereas other hypoglycemia manifestations such as dizziness and sweating are not 6. Nonselective beta-blockers have the capacity to intensify hypoglycemia brought on by insulin and to hinder the return of serum glucose to normal levels. In individuals who have both heart failure and diabetes, hyperglycemia may become worse 7. It may be necessary to monitor glucose more often or to modify the dose of the antidiabetic drug 12. During combined use, watch carefully for hypoglycemic signs and symptoms, and should the beta-blocker be discontinued, remain alert for a loss of glycemic control 3.

Why it happens (mechanism)

Altered glucose metabolism and beta blockade

How to manage this interaction

Keep taking both medications exactly as prescribed. Your care team can manage this interaction with a few simple steps:

  • Check your blood sugar more often so any highs or lows are caught early.
  • Your antidiabetic dose may be adjusted and individualized by your team as needed.
  • Be aware that a fast heartbeat, one classic low-sugar signal, may be muted, so watch for other clues like sweating.
  • If the beta-blocker is ever stopped, your team will watch for your blood sugar rising.

Tell your pharmacist or doctor if you notice unusual highs or lows, or symptoms that feel different than usual.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) In elderly diabetic patients receiving either insulin or sulfonylureas, the selection of antihypertensive agent had minimal impact on hypoglycemia risk; however, once other risk factors were taken into account, the lowest risk was seen with cardioselective beta blockers and the highest with non-cardioselective beta blockers, while other antihypertensive agents produced intermediate outcomes (N=13,559) 4.

b) In patients with hypertension and non-insulin dependent diabetes, beta blockers, but not alpha blockade or ACE inhibitors, produced a worsening of long-term glycemic control. Certain unfavorable changes in the lipid profile also occurred with beta blockade. These effects were particularly evident with propranolol. Using an alpha blocker together with the beta blocker prevented the worsening caused by beta blockade 5.

Common questions

Can I take Metipranolol and Acarbose together?

Using acarbose with the beta-blocker metipranolol can shift your blood sugar and may hide the racing-heart warning sign of a low. Keep both as prescribed, monitor your glucose a bit more closely, and let your care team fine-tune your doses. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Metipranolol and Acarbose interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How is the Metipranolol and Acarbose interaction managed?

Keep taking both medications exactly as prescribed. Your care team can manage this interaction with a few simple steps: Check your blood sugar more often so any highs or lows are caught early. Your antidiabetic dose may be adjusted and individualized by your team as needed. Be aware that a fast heartbeat, one classic low-sugar signal, may be muted, so watch for other clues like sweating. If the be… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Metipranolol or Acarbose need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (7)

  1. Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
  2. Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  3. Product Information: Glynase(R) PresTab(R) oral micronized tablets, glyburide oral micronized tablets. Pharmacia & Upjohn Co (per FDA), New York, NY, 2013. DailyMed
  4. Shorr RI, Ray WA, Daugherty JR, et al: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA 1997; 278:40-43. DOI
  5. Whitcroft IA, Thomas JM, Rawsthorne A, et al: Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics. Horm Metab Res Suppl 1990; 22:42-46.
  6. Product Information: TENORMIN(R) oral tablets, atenolol oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2012. DailyMed
  7. Product Information: COREG CR(R) extended-release oral capsules, carvedilol phosphate extended-release oral capsules. GlaxoSmithKline, Research Triangle Park, NC, 2011. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.